Glenmark Pharma Q4 seen up at Rs 47.8 cr

17864 Investors following Glenmark. Share this News with them.

0

Like this story, share it with millions of investors on M3

Glenmark Pharma Q4 seen up at Rs 47.8 cr

Glenmark Pharma is to announce its Q4FY07 result. According to the CNBC-TV18 estimates, the company is expected to post consolidated net profit of Rs 47.8 crore in Q4FY07 versus Rs 25 crore, up 91% YoY. During the same quarters, it is expected to report consolidated net sales of Rs 318 crore versus Rs 166.30 crore, YoY.

Post your opinion here

 

0

Tweet

Share on Tumblr

ALSO READ News and Notices about Glenmark See interviews with Glenmark Management See what other Experts & Brokerages are saying about Glenmark See previous Results of Glenmark Glenmark BSE | NSE 25/05/12 Are Mutual Funds betting on Glenmark?

Glenmark Pharma is to announce its Q4FY07 result. According to the CNBC-TV18 estimates, the company is expected to post consolidated net profit of Rs 47.8 crore in Q4FY07 versus Rs 25 crore, up 91% YoY. During the same quarters, it is expected to report consolidated net sales of Rs 318 crore versus Rs 166.30 crore, YoY.

The company's operating profit is seen up 104% at Rs 69 crore versus Rs 33.9 crore, YoY  and  operatin profit margin is likely to go up to 22% from 20%.